Get Instant Summarized Text (Gist) Chlamydia trachomatis forms protective inclusions by fusing their membranes to create large bacterial pockets inside human cells. This fusion process involves ...

If immune cells detect Chlamydia before it forms the inclusion, they trigger T cells to produce interferon-γ (IFN-γ), a powerful cytokine. IFN-γ activates the protein mysterin (also called RFN213), ...

Chlamydia is the most common sexually transmitted ... Yet, until now, scientists haven't been able to test this theory in ...

Illustration depicting a chlamydia-infected cell. Chlamydia trachomatis bacteria (represented by small dark spherical shapes colorized blue) undergo development within a membrane-enclosed ...

Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA ...

The FDA has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.

It's possible, but rare, to pass chlamydia to the throat through an act of oral sex with an infected man. Symptoms usually show up one to three weeks after infection, if they appear at all.

Koalas from a population north of the Brisbane River have evolved a unique genomic immunity to the killer retrovirus ...

Prompt treatment of chlamydia and gonorrhea following a confirmed diagnosis is essential to prevent complications and reduce ...

T he bacterium chlamydia trachomatis is a major cause of sexually transmitted diseases. Bacteria have lots of tricks up their sleeve that help them survive inside cells. One strategy that ...